Operating Income: The income after operating expenses.
Liminatus Pharma Inc. (LIMN) had Operating Income of $-2.97M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-10.21M |
|
-- |
|
-- |
|
$2.97M |
|
|
Operating Income |
$-2.97M |
$-7.24M |
|
$-10.21M |
|
$-10.21M |
|
$-10.21M |
|
$-10.21M |
|
$-10.21M |
|
$-10.21M |
|
$-2.97M |
|
$-2.97M |
|
23.75M |
|
23.75M |
|
$-0.43 |
|
$-0.43 |
|
| Balance Sheet Financials | |
$0.50M |
|
$0.01M |
|
$0.01M |
|
$0.51M |
|
$10.30M |
|
-- |
|
$0.03M |
|
$10.33M |
|
$-9.81M |
|
$-9.81M |
|
$-9.81M |
|
27.07M |
|
| Cash Flow Statement Financials | |
$-9.96M |
|
$-0.79M |
|
$11.03M |
|
$0.06M |
|
$0.34M |
|
$0.28M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.05 |
|
-- |
|
-- |
|
-- |
|
-0.15 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.98M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
103.99% |
|
103.99% |
|
-1990.37% |
|
103.99% |
|
$-0.36 |
|
$-0.42 |
|
$-0.42 |
|